August 25, 2026
Marietta Prosthodontist Dr. David Zelby Recognized as 2026 Castle Connolly Top Dentist
August 24, 2026
VERAXA and Secarna Report Positive Early Data in Antibody-Oligonucleotide Collaboration
August 24, 2026
VERAXA Biotech Advances VXA-222 Cancer Program Beyond Discovery Phase, Strengthens IP Portfolio
August 20, 2026
Study Finds Most Young Adults Already Show Signs of Cardiovascular-Kidney-Metabolic Syndrome
August 19, 2026
Quantum BioPharma’s Lucid-MS Targets Myelin Protection as New Approach to MS Treatment
August 19, 2026
Quantum BioPharma’s Lucid-MS Advances Toward Phase 2 Trials as MS Treatment Focus Expands Beyond Inflammation
August 17, 2026
Helix BioPharma Appoints Dr. Markus Loeffler as Chief Medical Officer to Drive Next Phase of Oncology Clinical Development
August 17, 2026
Cayenne Wellness Center to Host 5th Annual Hispanic Heritage Month Educational Summit on Sickle Cell Disease
August 15, 2026
Memoir Chronicles a Mother’s Decades-Long Fight to Reunite with Abducted Daughter Across Three Continents
August 14, 2026
Onco-Innovations Advances ONC010 Toward First-in-Human Trials with Key Manufacturing and Metabolic Studies
August 13, 2026
NeOnc’s NEO100 Shows Strong Survival Signal in Phase 2a, Paving Way for Regulatory Discussions
August 10, 2026
NanoViricides Gets Approval for Phase II Ebola Trial in DRC, Offering Oral Treatment Option
August 10, 2026
Telomir Pharmaceuticals Publishes Peer-Reviewed Data Supporting Telomir-Zn for Triple-Negative Breast Cancer
August 7, 2026
Quantum BioPharma’s Dual Strategy Targets Neurological Health with MS Drug and Alcohol Supplement
August 7, 2026
Spanish Case of Pork Tapeworm Mimicking Brain Cancer Underscores Diagnostic Challenges and Need for New Treatments
August 6, 2026
Keep A Breast Foundation Unveils 2026 High Desert Collection to Spark Conversations on Breast Health
August 6, 2026
Liquid Biopsy Could Predict Immunotherapy Response in Advanced Lung Cancer, Study Suggests
August 5, 2026
Onco-Innovations Integrates AI, Nanotech, and Targeted Therapy in New Cancer Drug Development
August 5, 2026
More than 3,000 Hospitals Recognized for Commitment to High-Quality Cardiovascular Care
August 3, 2026
Independent Research Highlights Potential for Broader Filovirus Vaccines, Supporting GeoVax’s MVA Platform
July 30, 2026
VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Advance BiTAC Cancer Therapy Platform
July 30, 2026
Dr. Lee Newcomer, Author of ‘UNMASKED,’ Signs With Creative Management Partners for Book Promotion
